Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of renal surgery for cortical neoplasms on lipid metabolism.
Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, Kane CJ, Wake RW, Patterson AL, Wan JY, Derweesh IH. Bagrodia A, et al. Among authors: mehrazin r. BJU Int. 2014 Dec;114(6):837-43. doi: 10.1111/bju.12744. Epub 2014 Jul 15. BJU Int. 2014. PMID: 24656182
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Galsky MD, Daneshmand S, Izadmehr S, Gonzalez-Kozlova E, Chan KG, Lewis S, Achkar BE, Dorff TB, Cetnar JP, Neil BO, D'Souza A, Mamtani R, Kyriakopoulos C, Jun T, Gogerly-Moragoda M, Brody R, Xie H, Nie K, Kelly G, Horowitz A, Kinoshita Y, Ellis E, Nose Y, Ioannou G, Cabal R, Del Valle DM, Haines GK, Wang L, Mouw KW, Samstein RM, Mehrazin R, Bhardwaj N, Yu M, Zhao Q, Kim-Schulze S, Sebra R, Zhu J, Gnjatic S, Sfakianos J, Pal SK. Galsky MD, et al. Among authors: mehrazin r. Nat Med. 2024 Apr;30(4):1211. doi: 10.1038/s41591-024-02814-0. Nat Med. 2024. PMID: 38242983 Free PMC article. No abstract available.
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial.
Galsky MD, Daneshmand S, Izadmehr S, Gonzalez-Kozlova E, Chan KG, Lewis S, Achkar BE, Dorff TB, Cetnar JP, Neil BO, D'Souza A, Mamtani R, Kyriakopoulos C, Jun T, Gogerly-Moragoda M, Brody R, Xie H, Nie K, Kelly G, Horowitz A, Kinoshita Y, Ellis E, Nose Y, Ioannou G, Cabal R, Del Valle DM, Haines GK, Wang L, Mouw KW, Samstein RM, Mehrazin R, Bhardwaj N, Yu M, Zhao Q, Kim-Schulze S, Sebra R, Zhu J, Gnjatic S, Sfakianos J, Pal SK. Galsky MD, et al. Among authors: mehrazin r. Nat Med. 2023 Nov;29(11):2825-2834. doi: 10.1038/s41591-023-02568-1. Epub 2023 Oct 2. Nat Med. 2023. PMID: 37783966 Free PMC article. Clinical Trial.
Novel signatures of prostate cancer progression and therapeutic resistance.
Wang J, Ben-David R, Mehrazin R, Yang W, Tewari AK, Kyprianou N. Wang J, et al. Among authors: mehrazin r. Expert Opin Ther Targets. 2023 Jul-Dec;27(12):1195-1206. doi: 10.1080/14728222.2023.2293757. Epub 2023 Dec 30. Expert Opin Ther Targets. 2023. PMID: 38108262 Review.
Erythropoietin-secreting metanephric adenoma presenting as erythrocytosis.
Liu A, Kremyanskaya M, Mehrazin R, Si Q, Robinson BD, Cushing MM, Hoffman R, Ginzburg YZ. Liu A, et al. Among authors: mehrazin r. Am J Hematol. 2023 Nov;98(11):1808-1813. doi: 10.1002/ajh.27047. Epub 2023 Aug 1. Am J Hematol. 2023. PMID: 37528578 No abstract available.
Robot-Assisted Repair of Ureteroenteric Strictures After Cystectomy with Urinary Diversion: Technique Description and Outcomes from the European Robotic Urology Section Scientific Working Group.
Rich JM, Tillu N, Grauer R, Busby D, Auer R, Breda A, Buse S, D'Hondt F, Falagario U, Hosseini A, Mehrazin R, Minervini A, Mottrie A, Sfakianos J, Palou J, Wijburg C, Wiklund P, John H. Rich JM, et al. Among authors: mehrazin r. J Endourol. 2023 Nov;37(11):1209-1215. doi: 10.1089/end.2023.0204. J Endourol. 2023. PMID: 37694596
145 results